杭州赫尔斯科技

Hangzhou Health Biotech is a specialized biotechnology company focused on the development and manufacturing of in vitro diagnostic (IVD) products. The company utilizes advanced lateral flow immunoassay and fluorescence chromatography platforms to produce rapid test kits for infectious diseases, drugs of abuse, and cardiac markers. Their portfolio includes widely distributed tests for COVID-19, HIV, and various respiratory pathogens, catering to both clinical and point-of-care settings. Based in Hangzhou, China, the firm maintains international quality standards including ISO 13485 and CE certifications to support its global export business. The company is recognized for its rapid response to public health needs and its commitment to providing accessible diagnostic solutions worldwide.